White Paper - A digital future for Value Added Medicines: Supporting positive patient behaviour, AURELIO ARIAS, Senior Consultant, European Thought Leadership, IQVIA, settembre 2019

Calls to action to improve access to value added medicines, febbraio 2019

Case Studies for Value Added Medicines -Unlocking the potential of patient-centric continuous innovation (Countries in scope: France, Germany, Italy, UK, Sweden, Poland), febbraio 2019

Perceptions and recommendations of physicians/KOLs on value added medicines, ottobre 2019, maggio 2018 – updated gennaio 2019

Value Added Medicines: Time to Adjust the HTA Decision Frameworks, settembre 2017

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access, maggio 2016